Filing Details
- Accession Number:
- 0001159036-14-000082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-16 19:43:18
- Reporting Period:
- 2014-09-16
- Filing Date:
- 2014-09-16
- Accepted Time:
- 2014-09-16 18:43:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1159036 | Halozyme Therapeutics Inc | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1528185 | Helen Torley | C/O Halozyme Therapeutics Inc. 11388 Sorrento Valley Road San Diego CA 92121 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-09-16 | 50,000 | $8.92 | 50,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple purchases at prices ranging from $8.76 to $9.00. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.